Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk, INFORISK Clinical Trial

  • Brotons, Carlos|||0000-0001-9388-6581
  • Moral Peláez, Irene|||0000-0002-3842-8796
  • Fernández, Diana
  • Puig Palma, Mireia|||0000-0001-6676-8432
  • Vilella, Teresa|||0000-0002-5281-4386
  • Puig Reixach, Maria Teresa|||0000-0003-1402-7653
  • Cuixart Costa, Lluís|||0000-0003-3073-514X
  • Férriz, Gemma
  • Pedro-Pijoan, Anna Maria|||0000-0001-5348-6612
  • Codinachs, Roger|||0000-0002-2888-1562
  • Rodríguez, Mónica
  • Fuentes, Rubén
Background: The concept of global cardiovascular risk is not usually well understood by patients in consultation. Methods: This was a multicenter, prospective, randomized, open clinical trial of one-year duration to evaluate the effectiveness in reducing global cardiovascular risk with an intervention aimed at high-risk patients to improve information on the cardiovascular risk compared to the usual care. The intervention was focused on providing information about cardiovascular risk in a more understandable way, explaining the best practices to reduce cardiovascular risk, and tailoring information to the individual. Results: Four-hundred and sixty-four subjects participated in the study; 59.3% were men, and the mean age was 61.0 (SD 8.0) years. Significant reductions in systolic blood pressure (SBP) (-3.12 mmHg), body mass index (BMI) (-0.34 kg/m 2), abdominal circumference (-1.24 cm), and REGICOR cardiovascular risk (-0.63) were observed in the intervention group. Overall, no differences in cardiovascular risk score were observed between groups at the end of follow-up. Conclusions: Providing an easy-to-understand assessment of the cardiovascular risk motivated high-risk patients to adopt a healthier lifestyle and improved cardiovascular risk after one year in the intervention group. Clinicians should assess a patient's baseline understanding of their CV risk using tools other than absolute risk before making treatment recommendations.